Introduction

Current Opinion in Immunology

Volumn 22, Issue 3, 2010, Pages 355-357

  Ertl, Hildegund C J ^a   Lanzavecchia, Antonio ^b  

^a WISTAR INSTITUTE   (United States)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; AMYLOID BETA PROTEIN; ANGIOTENSIN I; ANGIOTENSIN II; BCG VACCINE; CANCER VACCINE; CIRCUMSPOROZOITE PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 1BETA; INVARIANT NATURAL KILLER CELL AGONIST; MALARIA VACCINE; NEUTRALIZING ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR; RECOMBINANT HEPATITIS B SURFACE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACCINE; VIRUS ENVELOPE PROTEIN; IMMUNOLOGICAL ADJUVANT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DEGENERATIVE DISEASE; DRUG DESIGN; DRUG EFFICACY; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IMMUNE RESPONSE; INFECTION PREVENTION; MALARIA; NATURAL KILLER CELL; NEOPLASM; PROTEIN TARGETING; PUBLICATION; TUBERCULOSIS; COMMUNICABLE DISEASE; IMMUNOLOGY;

ADJUVANTS, IMMUNOLOGIC; ALZHEIMER DISEASE; AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; DRUG DESIGN; HUMANS; NEOPLASMS; VACCINES;

EID: 77953539839     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.05.001     Document Type: Editorial

References (8)

1. Knobel D.L., Cleaveland S., Coleman P.G., Fèvre E.M., Meltzer M.I., Miranda M.E., Shaw A., Zinsstag J., Meslin F.X. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005, 83:360-368.
2. Buchbinder S.P., Mehrotra D.V., Duerr A., Fitzgerald D.W., Mogg R., Li D., Gilbert P.B., Lama J.R., Marmor M., Del Rio C., et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008, 372:1881-1893.
3. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Rerks-Ngarm S., Pitisuttithum P., Paris R., Premsri N., Namwat C., et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009, 361:2209-2220.
4. Bejon P., Lusingu J., Olotu A., Leach A., Lievens M., Vekemans J., Mshamu S., Lang T., Gould J., Dubois M.C., et al. Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 2008, 359:2521-2532.
5. Rosenberg S.A., Restifo N.P., Yang J.C., Morgan R.A., Dudley M.E. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008, 8(April (4)):299-308. Review.
6. Kenter G.G., Welters M.J., Valentijn A.R., Lowik M.J., Berends-van der Meer D.M., Vloon A.P., Essahsah F., Fathers L.M., Offringa R., Drijfhout J.W., et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med 2009, 361:1838-1847.
7. Freeman G.J., Wherry E.J., Ahmed R., Sharpe A.H. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J Exp Med 2006, 203:2223-2227.
8. Salio M., Silk J.D., Cerundolo V. Recent advances in processing and presentation of CD1 bound lipid antigens. Curr Opin Immunol 2010, 22:81-88.